Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic.
Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic.
复制标题
DOI：
10.3390/endocrines2040040
复制
发表时间：
2021-12
期刊：
影响因子：
--
通讯作者：
Glaser NS
中科院分区：
文献类型：
--
作者：
Crossen SS;Romero CC;Loomba LA;Glaser NS
新冠肺炎大流行导致远程医疗被广泛采用来管理诸如1型糖尿病(T1D)等慢性疾病，但在此期间收集的关于患者体验和感知护理质量的数据很少。我们调查了T1D交换患者登记处和在线社区的成员，了解他们在大流行期间使用远程医疗护理的经验和意见。在2235名受访者中，65%的人使用过远程医疗。采用远程医疗的最常见原因是不提供面对面护理的提供者(66%)、对面对面护理的健康风险的担忧(59%)、提供者首次提供远程医疗(52%)或保险(19%)，以及地方或州命令留在家里(33%)。在远程医疗用户中，62%的人认为视频护理与面对面护理一样有效或更有效，82%的人希望未来使用远程医疗。不使用远程医疗的最主要原因是提供者没有提供远程医疗(49%)。我们的发现强调了远程医疗在新冠肺炎大流行期间维持获得T1D护理方面的作用。受访者对远程医疗的满意度和对继续使用远程医疗的兴趣表明，需要不断获得这种护理模式，并在T1D护理中发展远程医疗最佳实践。
The COVID-19 pandemic has resulted in widespread adoption of telemedicine for management of chronic conditions such as type 1 diabetes (T1D), but few data have been collected about the patient experience and perceived quality of care during this time. We surveyed members of the T1D Exchange patient registry and online community regarding their experiences with and opinions about telemedicine care during the pandemic. Among 2235 survey respondents, 65% had utilized telemedicine. The most common reasons for adopting telemedicine were providers not offering in-person care (66%), concerns about the health risks of in-person care (59%), providers offering (52%) or insurance covering (19%) telemedicine for the first time, and local or state orders to stay home (33%). Among telemedicine users, 62% felt video care was as effective as or more effective than in-person care, and 82% hoped to use telemedicine in the future. The most-cited reason for non-use of telemedicine was that providers were not offering it (49%). Our findings highlight the role of telemedicine in maintaining access to T1D care during the COVID-19 pandemic. Respondents’ satisfaction with telemedicine and interest in its continued use signifies the need for ongoing access to this care modality and for the development of telemedicine best practices within T1D care.